Aim of the study : This study was designed to test if spiral CTA is associated with increased risk of contrast nephropathy in high-risk patients with renal insufficiency.
We recently found that the incidence of hypertension and femoral intimamedia thickness (IMT) are influenced by epistatic interactions between the genes encoding ACE (I/D polymorphism), ␣-adducin (Gly460Trp) and aldosterone synthase (-344C/T). By interfering with BP or Na ϩ homeostasis, these genetic polymorphisms may also change renal function. We therefore genotyped a random population sample for these 3 genes. We measured serum creatinine and uric acid and 24-h urinary protein excretion and determined calculated and measured creatinine clearances (CrCl). The 1454 participants (64.3% of those invited) were 43.4 years old and included 744 women (51.2%). The prevalence of renal dysfunction (CrCl Յ60 mL/min/1.73 m 2 ) was 11%. The BP measured by the study nurses at the subjects' homes averaged 123/76 mm Hg. Mean values were 90 mol/L for serum creatinine, 300 mol/L for serum uric acid (nϭ1194), 90 mg/day for proteinuria (nϭ556), and 84 and 88 mL/min/1.73 m 2 for calculated and measured (nϭ855) CrCls, respectively. In single-gene analyses with adjustment for significant covariates, serum creatinine, proteinuria and the risk of mild renal dysfunction were positively associated with the ACE D allele. However, these relations with the ACE D allele were confined to carriers of the mutated ␣-adducin Trp allele (40.1% of all subjects), in whom serum creatinine, proteinuria and the relative risk of mild renal dysfunction were 4.3 mol/L (Pϭ0.003), 20% (Pϭ0.02) and 302% (PϽ0.001) higher in carriers of the ACE D allele than in II homozygotes. The presence of the aldosteronesynthase T allele did not add to the association between renal function and the ACE D allele. Thus, in our cross-sectional population study, renal function was slightly but consistently impaired when both the ACE D and ␣-adducin Trp alleles were present. These findings, taken together with experimental studies and our previous reports on the incidence of hypertension and femoral IMT, constitute a growing body of evidence delineating a clinical entity genetically determined by the risk-carrying ACE D and ␣-adducin Trp alleles. NSAIDs inhibit renal prostaglandin synthesis, affect control of hypertension, and are risk factors for congestive heart failure (CHF). COX-2-specific NSAIDs also affect renal function, increase BP, and have been associated with an increase in myocardial infarctions (VIGOR study). N is not a specific COX-2 inhibitor, but has little effect on renal prostaglandin secretion and had less of an association with CHF than IB or traditional NSAIDs in a large cohort study (1). Effects on BP (mean of 3 sitting measurements) were studied in a double-blind, randomized, placebo-controlled 1-month study of N 1g bid (nϭ91), C 200mg bid (nϭ87), IB 800 mg tid (nϭ91) and P (nϭ91) in hypertensive patients (18-75 yrs) stabilized for Ͼ 3 months (DBP Ͻ95 mm Hg) on ACE inhibitors uid. normal range, and ambulatory (A) blood pressure (BP) in patients with essential hypertension (EH). Seventy-one (71) patients ( mean age 47.2 years) with never-treated EH diagnosed within the last year, and with conventional measured diastolic (D) BP Ͼ 95 mm Hg referred to the Hypertension Clinic (Ulleval University Hospital) for ABP monitoring (M), were included. Patients with diabetes mellitus, left ventricular hypertrophy, elevated serum creatinine Ͼ 130 mol/L, postive urine dipstick for albumin or glucose were not eligible. AER was evaluated by albumin/creatinine ratio (ACR) in the first-voided morning urine sample taken at the end of the ABPM, and LVM was assessed by the Cornell voltage-QRS duration product corrected for gender. Patients with ACR Ն3.0 mg/mmol and left ventricular hypertrophy (LVH, Cornell product Ͼ 2440 mm·ms) were excluded (nϭ3), and further analyses were undertaken in 68 patients (51 men and 17 women).
ACR correlated with 24-hour, daytime and nighttime both systolic (S) BP and DBP (rϭ0.42-0.53, all p values Ͻ 0.0005). There was a weak, but significant correlation between nocturnal SBP and DBP fall and ACR (rϭ-0.26, pϽ0.05 and rϭ-0.28, p Ͻ 0.05 respectively). All BPs were higher in the top tertile of ACR compared to the two lower tertiles. There was a statistical significant trend towards increased values of Cornell product with higher ACR, and this trend remained significant after adjustment of age, gender, body mass index and 24-hour pulse pressure (pϭ0.002). Patients in the top tertile of Cornell product had higher levels of ABP as well as higher values of ACR. Cornell product was significantly related to ABPs (rϭ0.32-0.37, all p Ͻ 0.001) and ACR (rϭ0.36, p Ͻ 0.005). A stepwise multiple regression analysis showed that only SBP was independently and significantly correlated with Cornell product ( ␤ϭ0.372, pϭ0.002). Of the variables excluded from the regression model, the highest partial correlation coefficient with Cornell product was observed for ACR (␤ϭ0.328, pϭ0.077).
In conclusion, our findings indicate early cardiac and renal involvement in untreated patients with EH. Continuous relationships between LVM, ACR and ABPs are observed, and values within the "normal range" of LVM and ACR may also be clinically relevant.
Key Words: Urinary albumin excretion, Ambulatory blood pressure, Left ventricular mass Objective: We evaluated the blood pressure lowering activity, tolerability and safety of Irbesartan (I) in 32 elderly hypertensive (sitting diastolic blood pressure, 90 to 115 mmHg) patients with chronic renal insufficiency including mild renal insufficiency (30 to 60 ml/min x 1.73 m 2 ; nϭ30), moderate to severe renal insufficiency (10 to 29 ml/min x 1.73 m 2 ; nϭ2) in one year trial. Design and Methods: After a 3-week placebo period, once daily I was administered for 12 months at daily dose of 150 mg. A second, nonangiotensin-converting enzyme inhibitor, antihypertensive drug was added after 8 weeks as needed. Twenty-four-hour creatinine clearance was determined and renal clearance studies of inulin and paraminohippurate were done in a subset of 11 patients.
P-168 LONG TERM EFFICACY AND TOLERABILITY OF IRBESARTAN IN ELDERLY HYPERTENSIVE PATIENTS WITH RENAL IMPAIRMENT
Results:Through sitting blood pressure were reduced at the end of the first week in all groups. At weeks 4, 8, 12 and after one year the reductions in systolic blood pressure/diastolic blood pressure averaged were -11.9/-8.7,-10.8/-9.4,and -14.7/-12.1mmHg in patients with mild renal insufficiency; -7.7/-6.3,-13.1/-11.8, and -14.1/-10.6 mmHg in moderate to severe renal insufficiency.Creatine clearance,glomerular filtration rate and effective renal plasma flow were stable.I was withdrawn in only 6 patients because of a clinical or laboratory adverse experience.
Hyperkaliemia(Ͼ6mEq/L) requiring discontinuation of I occurred in only one(group 2)patient.
Conclusion:We conclude that once-daily I given as monotherapy at dose of 150 mg or in combination with other antihypertensive drugs,was effective in reducing blood pressure in elderly hypertensive patients with chronic renal disease and that I regimens were well tolerated in all groups.
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P-169 RENAL HYALINE ARTERIOLOSCLEROSIS -A MARKER FOR LOSS OF AUTOREGULATION?
Gary S. Hill, Didier Heudes, Jean Bariety.
1 Nephrologie, Hopital Broussais and INSERM U 430, Paris, France Morphometric measurements were made of 143 glomerular-arteriolar pairs from normal portions of 10 kidneys removed for cancer. Compared with 70 normal arterioles, 38 afferent arterioles with nonobstructive hyaline deposits had larger lumens: Area: 416 Ϯ 245 vs 203 Ϯ 160 2 , p ϭ .0000; Diameter: 15.7 Ϯ 4.8 vs 11.7 Ϯ 3.9, p ϭ .0000. Circumference of these arterioles was also greater: 147 Ϯ 66 vs 94 Ϯ 49, p ϭ .0000. The muscularis beneath deposits was thinner than in the rest of the arteriole (7.8 Ϯ 3.9 vs 16.5 Ϯ 5.7, p ϭ .0000.
Associated glomeruli had greater overall capillary surface area (13,242 Ϯ 5,670 vs 11,069 Ϯ 5,897 2 , p ϭ .0337), with larger hilar capillaries (706 Ϯ 1038 vs 275 Ϯ 455 2 , p ϭ .0024) and larger individual peripheral capillaries (96 Ϯ 29 vs 84 Ϯ 28 2 , p ϭ .0476). There was a good correlation between area of arteriolar lumen and area of individual capillaries, both for normal arterioles (r ϭ .3192, pϽ.0001) and for arterioles with nonobstructive hyaline deposits (r ϭ .4693, pϽ.0001).
Arterioles with hyaline deposits partially obstructing the lumen were less frequent (19/57 ϭ 33% of cases), showed no overall differences in area of lumen from normal arterioles and were not significantly correlated with capillary size (r ϭ -.1137, NS).
Thus, hyaline arteriolosclerosis in its initial phases does not appear to impede blood flow but rather, given the larger lumens and larger glomerular capillary loops, may be a rough indicator of hyperperfusion and loss of autoregulation, perhaps as a function of the associated thinning and degeneration of the underlying smooth muscle. Renal transplant recipients bear an enhanced cardiovascular mortality. Left ventricular hyper-trophy (LVH) and elevated pulse pressure are considered cardiovascular risk factors. LVH is common in allografted patients, whereas pulse pressure has not yet been assessed in this pati-ent population, but has been shown to be strongly and independently associated with LVH in patients with chronic uremia. The objective of the study was to investigate the association between LVH and pulse pressure over a long-term in renal transplant recipients. 67 renal transplant recipients were examined clinically and echocardiographically shortly before and during the first 12 posttransplantational months. Cardiac mass was determined using M-mode echocardiography. Noninvasive blood pressure was measured using a sphygomanometer and the dinamap device. Data of 38 patients (age: 47.4 Ϯ 2.2 years; BMI: 23 Ϯ 0.5 kg/m2 ; duration of hemodialysis: 53.3 Ϯ 6.4 months; mean Ϯ SEM), who 86A AJH-April 2001-VOL. 14, NO. 4 , PART 2 POSTERS: Kidney and Hypertension
